Incidence of comorbidities in hospitalized chronic obstructive pulmonary disease patients and correlated risk factors

National Medical Journal of China

Volumn 92, Issue 14, 2012, Pages 943-947

  Chang, Chun ^a   Yao, Wan Zhen ^a   Fang, Tian Shu ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Comorbidities; Inpatients; Pulmonary disease, chronic obstructive; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; INPATIENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84868291458     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.14.004     Document Type: Article

References (22)

1. Feary J R, Rodrigues L C, Smith C J, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax, 2010, 65: 956-962.
2. 2011, 91: 824-827.
3. Garcia-Aymerich J, Gomez F P, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax, 2011, 66: 430-437.
4. 2007, 46: 254-261.
5. 1981, 9: 75-76.
6. 2004, 12: 156-161.
7. 2007, 35: 1076-1095.
8. 2006: 3.
9. 2008, 88: 1227-1245.
10. 2007, 35: 390-419.
11. 2002, 23: 5-10.
12. Holguin F, Folch E, Redd S C, et al. Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001. Chest, 2005, 128: 2005-2011.
13. Anthonisen N R, Connett J E, Enright P L, et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med, 2002, 166: 333-339.
14. 1. The Lung Health Study. JAMA, 1994, 272: 1497-1505.
15. Garcia-Aymerich J, Gómez F P, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax, 2011, 66: 430-437.
16. Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis, 2008, 5: 35-41.
17. Tomoda K, Yoshikawa M, Itoh T, et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest, 2007, 132: 135-140.
18. Sin D D, Man S F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation, 2003, 107: 1514-1519.
19. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil, 2005, 25: 226-232: discussion 233-234.
20. Watz H, Waschki B, Kirsten A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest, 2009, 136: 1039-1046.
21. Stanciu S, Marinescu R, Iordache M, et al. Are systemic inflammatory profiles different in patients with COPD and metabolic syndrome as compared to those with COPD alone? Rom J Intern Med, 2009, 47: 381-386.
22. de Lucas-Ramos P, Izquierdo-Alonso J L, Rodriguez-Gonzalez Moro J M, et al. Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study. Arch Bronconeumol, 2008, 44: 233-238.